UCB: Clinical Trials & Research Profile

Biopharma Industry (Brussels, BE / Atlanta, GA) · Primary Focus: Immunology, Rheumatology, and Dermatology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Brussels, BE / Atlanta, GA)
Primary Therapeutic AreaImmunology, Rheumatology, and Dermatology
Active Phase II & III Studies22 active (14 recruiting now)
Total Tracked Studies (2018 to 2026)86 (54 with California sites)
Completed vs Early-Stopped Studies49 completed / 15 stopped (17.4% stop rate)
Median Closed Enrollment111 participants
FDA Drugs@FDA Original Approvals30 all-time (6 from 2018 to 2026)
Physical Hospital Site Disclosure100.0% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for UCB across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk